Perspective Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2003
Net Income	-46.51	-7.27	-3.39	-3.46	-5.16	-6.71	-6.17	-4.72	-3.69	-6.7	Upgrade
Depreciation & Amortization	1.06	0.29	0.19	0.19	0.19	0.13	0.11	0.58	0.61	0.72	Upgrade
Share-Based Compensation	3.74	1.09	0.39	0.5	0.42	0.4	0.37	0.29	0.21	0.19	Upgrade
Other Operating Activities	4.8	-1.82	-0.03	-0.88	-0.51	0.45	-0.04	-0.04	-0.66	1.83	Upgrade
Operating Cash Flow	-36.91	-7.71	-2.84	-3.64	-5.05	-5.71	-5.71	-3.88	-3.52	-3.23	Upgrade
Capital Expenditures	-1.07	-0.27	-0.38	-0.27	-0.41	-0.34	-0.54	-0.48	-0.13	-0.02	Upgrade
Acquisitions	2.7	0	0	0	0	0	0	0	0	0	Upgrade
Change in Investments	22.76	0	0	0	0.83	2.21	2.18	9.25	0.94	-15.4	Upgrade
Other Investing Activities	-0.02	-0.02	-0.03	-0.01	-0.01	-0.02	-0.12	-0.01	-0.02	-0.02	Upgrade
Investing Cash Flow	24.37	-0.28	-0.41	-0.29	0.4	1.86	1.51	8.76	0.78	-15.44	Upgrade
Share Issuance / Repurchase	0.85	0.06	64.69	1.01	7.39	0.53	0	0.05	0.3	21.98	Upgrade
Debt Issued / Paid	-0.07	0	0	0	0	0	0	0	0	0	Upgrade
Other Financing Activities	-	-	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	1.47	Upgrade
Financing Cash Flow	0.79	0.06	64.68	0.99	7.37	0.52	-0.01	0.04	0.29	23.45	Upgrade
Net Cash Flow	-11.76	-7.94	61.44	-2.93	2.73	-3.33	-4.21	4.91	-2.45	4.78	Upgrade
Free Cash Flow	-37.99	-7.98	-3.22	-3.91	-5.46	-6.05	-6.26	-4.36	-3.66	-3.25	Upgrade
Free Cash Flow Margin	-2648.88%	-	-32.00%	-40.43%	-74.64%	-102.13%	-131.38%	-91.49%	-79.35%	-76.96%	Upgrade
Free Cash Flow Per Share	-0.14	-0.06	-0.03	-0.06	-0.08	-0.11	-0.11	-0.08	-0.07	-0.08	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).